NCT00009581View on ClinicalTrials.gov

Nitric Oxide to Improve Blood Flow in Sickle Cell Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

January 31, 2003

Conditions
Sickle Cell Anemia
Interventions
DRUG

L-NMMA

DRUG

Acetylcholine

Trial Locations (1)

20892

Warren G. Magnuson Clinical Center (CC), Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00009581 - Nitric Oxide to Improve Blood Flow in Sickle Cell Disease | Biotech Hunter | Biotech Hunter